- Home
- AMPY vs RAPT Comparison
AMPY vs RAPT Comparison
Compare AMPY & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPY
- RAPT
- Stock Information
- Founded
- AMPY 2011
- RAPT 2015
- Country
- AMPY United States
- RAPT United States
- Employees
- AMPY N/A
- RAPT N/A
- Industry
- AMPY Oil & Gas Production
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- AMPY Energy
- RAPT Health Care
- Exchange
- AMPY Nasdaq
- RAPT Nasdaq
- Market Cap
- AMPY 118.2M
- RAPT 117.5M
- IPO Year
- AMPY 2011
- RAPT 2019
- Fundamental
- Price
- AMPY $3.25
- RAPT $1.17
- Analyst Decision
- AMPY Strong Buy
- RAPT Buy
- Analyst Count
- AMPY 2
- RAPT 5
- Target Price
- AMPY $10.25
- RAPT $5.25
- AVG Volume (30 Days)
- AMPY 718.0K
- RAPT 1.0M
- Earning Date
- AMPY 05-12-2025
- RAPT 05-08-2025
- Dividend Yield
- AMPY N/A
- RAPT N/A
- EPS Growth
- AMPY N/A
- RAPT N/A
- EPS
- AMPY 0.39
- RAPT N/A
- Revenue
- AMPY $290,431,100.00
- RAPT N/A
- Revenue This Year
- AMPY $6.42
- RAPT N/A
- Revenue Next Year
- AMPY $45.85
- RAPT N/A
- P/E Ratio
- AMPY $8.24
- RAPT N/A
- Revenue Growth
- AMPY N/A
- RAPT N/A
- 52 Week Low
- AMPY $2.27
- RAPT $0.71
- 52 Week High
- AMPY $8.15
- RAPT $4.21
- Technical
- Relative Strength Index (RSI)
- AMPY 61.93
- RAPT 61.69
- Support Level
- AMPY $3.18
- RAPT $0.99
- Resistance Level
- AMPY $3.46
- RAPT $1.05
- Average True Range (ATR)
- AMPY 0.17
- RAPT 0.13
- MACD
- AMPY 0.07
- RAPT 0.02
- Stochastic Oscillator
- AMPY 75.58
- RAPT 78.35
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.